han Zhang

han Zhang


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 December 2022 in Antioxidants
Verified
Journal Article
Open access
PDF file
LBLu Bai
Lu Bai
DXDong Xu
Dong Xu
ZYzhou Yanming
zhou Yanming
YZYong-Bo Zhang
Yong-Bo Zhang
HZhan Zhang
han Zhang
YCYuan-Lu Cui
Yuan-Lu Cui
Many chronic diseases such as Alzheimer’s disease, diabetes, and cardiovascular diseases are closely related to in vivo oxidative stress caused by excessive reactive oxygen species (ROS). Natural polysaccharides, as a kind of biomacromolecule with good biocompatibility, have been widely used in biomedical and medicinal applications due to their superior antioxidant properties. In this review, scientometric analysis of the highly cited papers in the Web of Science (WOS) database finds that antioxidant activity is the most widely studied and popular among pharmacological effects of natural polysaccharides. The antioxidant mechanisms of natural polysaccharides mainly contain the regulation of signal transduction pathways, the activation of enzymes, and the scavenging of free radicals. We continuously discuss the antioxidant activities of natural polysaccharides and their derivatives. At the same time, we summarize their applications in the field of pharmaceutics/drug delivery, tissue engineering, and antimicrobial food additives/packaging materials. Overall, this review provides up-to-date information for the further development and application of natural polysaccharides with antioxidant activities.

13 January 2022 in Pharmacological Research
Verified
Journal Article
Closed access
YWYuying Wang
Yuying Wang
XWXi Wang
Xi Wang
YLYixuan Li
Yixuan Li
ZXZhifeng Xue
Zhifeng Xue
RSRui Shao
Rui Shao
JYJian Yang
Jian Yang

20 November 2019 in Phytotherapy Research
Verified
Journal Article
Open access
TLtao liu
tao liu
NLNan Li
Nan Li
YYYi‐Qi Yan
Yi‐Qi Yan
KXKe Xiong
Ke Xiong
YLYang Liu
Yang Liu
ZLZhidong Liu
Zhidong Liu
Skin undergoes degenerative changes as it ages, which include the loss of elasticity, reductions in the epidermal thickness and collagen content, elastic fiber degeneration, and increased wrinkling and dryness. Skin aging can be significantly delayed by the administration of estrogen. Estrogen deficiency following menopause results in atrophic skin changes and the acceleration of skin aging. Estrogen administration has positive effects on human skin by delaying or preventing skin aging manifestations, but the use of estrogen replacement is a risk factor for breast and uterine cancer. Phytoestrogens are a large family of plant‐derived molecules possessing various degrees of estrogen‐like activity; they exhibit agonist or antagonist estrogenic properties depending on the tissue. These molecules could be ideal candidates to combat skin aging and other detrimental effects of hypoestrogenism. In this paper, we review the effects of phytoestrogens on human skin and the mechanisms by which phytoestrogens can alleviate the changes due to aging.

1 October 2021 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
YWYuying Wang
Yuying Wang
XSXiaoqing Sang
Xiaoqing Sang
RSRui Shao
Rui Shao
HQHonglin Qin
Honglin Qin
XCXuanhao Chen
Xuanhao Chen
JYJian Yang
Jian Yang

19 September 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
YZYong-Bo Zhang
Yong-Bo Zhang
DXDong Xu
Dong Xu
LBLu Bai
Lu Bai
ZYzhou Yanming
zhou Yanming
HZhan Zhang
han Zhang
YCYuan-Lu Cui
Yuan-Lu Cui
With rapid and non-invasive characteristics, the respiratory route of administration has drawn significant attention compared with the limitations of conventional routes. Respiratory delivery can bypass the physiological barrier to achieve local and systemic disease treatment. A scientometric analysis and review were used to analyze how respiratory delivery can contribute to local and systemic therapy. The literature data obtained from the Web of Science Core Collection database showed an increasing worldwide tendency toward respiratory delivery from 1998 to 2020. Keywords analysis suggested that nasal and pulmonary drug delivery are the leading research topics in respiratory delivery. Based on the results of scientometric analysis, the research hotspots mainly included therapy for central nervous systems (CNS) disorders (Parkinson’s disease, Alzheimer’s disease, depression, glioblastoma, and epilepsy), tracheal and bronchial or lung diseases (chronic obstructive pulmonary disease, asthma, acute lung injury or respiratory distress syndrome, lung cancer, and idiopathic pulmonary fibrosis), and systemic diseases (diabetes and COVID-19). The study of advanced preparations contained nano drug delivery systems of the respiratory route, drug delivery barriers investigation (blood-brain barrier, BBB), and chitosan-based biomaterials for respiratory delivery. These results provided researchers with future research directions related to respiratory delivery.

Verified
Journal Article
Open access
PDF file
XFXiang Fan
Xiang Fan
LClijuan Chai
lijuan Chai
HZhan Zhang
han Zhang
HYHuijuan Yu
Huijuan Yu
BZBoli Zhang
Boli Zhang
XGXiu-Mei Gao
Xiu-Mei Gao
P-glycoprotein (P-gp) on brain microvascular endothelial cells (BMECs) that form the blood brain barrier (BBB), influences transportation of substances between blood and brain. The objective of this study was to characterize the effects of borneol on P-gp efflux function on BBB and explore the potential mechanisms. We established an in vitro BBB model comprised of rat BMECs and astrocytes to measure the effects of borneol on the known P-gp substrates transport across BBB, and examined the function and expression of P-gp in BMECs and the signaling pathways regulating P-gp expression. Borneol increased intracellular accumulation of Rhodamine 123, enhanced verapamil and digoxin across the BBB in vitro model, and depressed mdr1a mRNA and P-gp expression. Borneol could activate nuclear factor-κB (NF-κB) and inhibition of NF-κB with MG132 (carbobenzoxy-Leu-Leu-leucinal) and SN50 (an inhibitory peptide) obscuring the P-gp decreases induced by borneol. These data suggested that borneol depresses P-gp function in BMECs by a NF-κB signaling medicated mechanism in a BBB in vitro model.